E. Heervä

E. Jokinen, T. Kuorilehto, S. Peltonen, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

NEUROFIBROMATOSIS 1 (NF1)

J. Peltonen, E. Heervä, Eetu Heervä, 2013 .

Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player

V. Kähäri, S. Peltonen, J. Peltonen, 2021, Molecular Biology Reports.

Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma.

H. Minn, P. Vihinen, E. Heervä, 2023, Acta dermato-venereologica.

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

J. Kononen, E. Lantto, H. Isoniemi, 2021, The Lancet regional health. Europe.

J. Kononen, H. Sintonen, H. Isoniemi, 2022, Cancers.

An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer

H. Minn, O. Carpén, H. Huhtinen, 2020, Acta oncologica.

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)

J. Kononen, H. Isoniemi, B. Glimelius, 2023, Journal of clinical medicine.

Follow-Up of Six Patients with Neurofibromatosis 1-Related Osteoporosis Treated with Alendronate for 23 Months

S. Peltonen, J. Peltonen, P. Leinonen, 2014, Calcified Tissue International.

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer

C. Haglund, H. Joensuu, P. Kellokumpu-Lehtinen, 2023, International journal of molecular sciences.

Improved risk prediction of chemotherapy‐induced neutropenia—model development and validation with real‐world data

L. Elo, M. Bärlund, M. Venäläinen, 2021, Cancer medicine.

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

J. Kononen, T. Kuopio, A. Ristimäki, 2022, The British journal of surgery.

Overall Survival and Metastasis Resections in Patients with Metastatic Colorectal Cancer Using Electronic Medical Records

H. Minn, P. Jaakkola, R. Ristamäki, 2018, Journal of Gastrointestinal Cancer.

Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

T. Sjöblom, T. Kuopio, H. Sorbye, 2023, International journal of cancer.

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

J. Sundström, T. Salminen, R. Ristamäki, 2024, Cancers.

Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).

H. Sorbye, P. Flygare, B. Glimelius, 2024, Acta oncologica.

Controlled register‐based study of road traffic accidents in 12,651 Finnish cancer patients during 2013–2019

V. Kytö, N. Sihvola, S. Jyrkkiö, 2022, Cancer medicine.

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)

N. Lundbom, R. Blanco Sequeiros, A. Ristimäki, 2021, ESMO open.